Cyrus Biotechnology

Seattle, United States

Cyrus Biotechnology is a developer of Rosetta software platform that solves drug discovery problems.

Feb 2024

Series B

Biotechnology Nutrition Software

Top Investors

Alumni Ventures OrbiMed Alexandria Venture Investments Trinity Ventures Agent Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cyrus Biotechnology

Who are Cyrus Biotechnology's investors?

Cyrus Biotechnology's investors include Alumni Ventures, OrbiMed, Alexandria Venture Investments, Trinity Ventures, Agent Capital.

Where is Cyrus Biotechnology headquartered?

Cyrus Biotechnology is headquartered in Seattle, United States.

What does Cyrus Biotechnology do?

Cyrus Biotechnology is a developer of Rosetta software platform that solves drug discovery problems.

What stage is Cyrus Biotechnology at?

Cyrus Biotechnology is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 26, 2024.

MLA

"Cyrus Biotechnology — Funding & Investors." VCBacked, February 26, 2024, https://www.vcbacked.co/company/cyrus-biotechnology. Accessed July 1, 2026.

APA

VCBacked. (2024). Cyrus Biotechnology — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/cyrus-biotechnology

Wikipedia (cite web)

{{cite web |title=Cyrus Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/cyrus-biotechnology |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 26, 2024.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K